Telcos have indicated that rates will have to be raised, as higher volumes alone will not suffice to meet the higher costs.
Infosys' aspirations to improve revenue per employee might also prove to be a tall task, believe analysts.
There, however, has been an improvement in operating margins.
The challenge of merging Ranbaxy into the company has not been factored in.
Tech major's shareholders will receive total dividend of Rs 15,474 crore in FY15
The talent gap in the industry is huge, says N Chandrasekaran, MD & CEO, TCS.
Recent rates cuts by most banks may not have a significant impact on margins, say analysts.
For equity investors, the risk-to-reward ratio is worsening.
It was a year of big gains for equity investors.
Corporates' forex borrowings have grown at a CAGR of 15.6% since 2008.
Corporate India at present is more indebted than all state govts put together.
Given the better growth in JLR sales and improving domestic sales, nearly 90 per cent of the analysts covering the stock have a 'Buy' rating.
Through the past 12 months, the Bank Nifty has risen 55%
SBI remains a favourite of most brokerages in the PSB segment.
Dilip Shanghvi founded Sun Pharma in 1983.
Stock prices is due to valuation expansion
Oil imports are a third of India's total import bill.
HUL, UltraTech, Asian Paints, L&T, HDFC Bank top global valuation charts
Sales expansion also down 4.4%
TCS had in recent weeks been the subject of reports of a large number of layoffs.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances